Northwestern Mutual Wealth Management Co. Invests $12.47 Million in CVS Health Corporation $CVS

Key Points

• Northwestern Mutual Wealth Management acquired 120,524 CVS Health shares worth approximately $12.47 million during the second quarter. Institutional investors collectively own 80.66% of the company.
• CVS reported quarterly earnings of $2.58 per share, beating estimates of $1.87, while revenue rose 7.3% year over year to $106.10 billion. The company guided to fiscal 2026 EPS of $7.90–$8.10.
• Analysts maintain a favorable outlook, with a consensus “Moderate Buy” rating and an average price target of $107.17. CVS also pays a quarterly dividend of $0.665 per share, yielding about 2.9% annually.

Northwestern Mutual Wealth Management Co. acquired a new stake in CVS Health Corporation (NYSE:CVS - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 120,524 shares of the pharmacy operator's stock, valued at approximately $12,468,000.

A number of other institutional investors have also recently bought and sold shares of CVS. Cadence Wealth Management LLC bought a new stake in shares of CVS Health during the 2nd quarter valued at $370,000. Evolve Private Wealth LLC bought a new position in shares of CVS Health in the 2nd quarter worth $4,976,000. Varma Mutual Pension Insurance Co acquired a new stake in shares of CVS Health during the second quarter worth $22,073,000. Forum Private Client Group LLC acquired a new stake in shares of CVS Health during the second quarter worth $428,000. Finally, Emerald Investment Advisers LLC bought a new stake in CVS Health in the second quarter valued at about $1,807,000. Institutional investors and hedge funds own 80.66% of the company's stock.

CVS Health Stock Performance

CVS opened at $93.01 on Friday. The business's 50-day moving average price is $102.02 and its two-hundred day moving average price is $88.86. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The company has a market capitalization of $118.96 billion, a price-to-earnings ratio of 24.61, a P/E/G ratio of 0.85 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.71. The company had revenue of $106.10 billion during the quarter, compared to analysts' expectations of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.CVS Health's revenue for the quarter was up 7.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts expect that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health's dividend payout ratio (DPR) is currently 70.37%.

Analyst Ratings Changes

A number of brokerages have issued reports on CVS. JPMorgan Chase & Co. raised their target price on CVS Health from $111.00 to $118.00 and gave the stock an "overweight" rating in a report on Wednesday, August 12th. Morgan Stanley upped their price target on CVS Health from $106.00 to $111.00 and gave the company an "overweight" rating in a research note on Thursday, June 4th. Sanford C. Bernstein lifted their price objective on shares of CVS Health from $94.00 to $106.00 and gave the stock an "outperform" rating in a research note on Tuesday, May 12th. TD Cowen boosted their price objective on shares of CVS Health from $105.00 to $110.00 and gave the company a "buy" rating in a report on Monday, May 11th. Finally, DA Davidson increased their target price on shares of CVS Health from $80.00 to $100.00 and gave the stock a "buy" rating in a report on Thursday, May 7th. Twenty-two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $107.17.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source